EG16212A - Procede pour l'obtention de composes a noyau heterocyclique diazote - Google Patents

Procede pour l'obtention de composes a noyau heterocyclique diazote

Info

Publication number
EG16212A
EG16212A EG40/84A EG4084A EG16212A EG 16212 A EG16212 A EG 16212A EG 40/84 A EG40/84 A EG 40/84A EG 4084 A EG4084 A EG 4084A EG 16212 A EG16212 A EG 16212A
Authority
EG
Egypt
Prior art keywords
heterocyclique
diazote
noyau
obtention
composes
Prior art date
Application number
EG40/84A
Other languages
English (en)
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of EG16212A publication Critical patent/EG16212A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Polymerisation Methods In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EG40/84A 1983-01-21 1984-01-21 Procede pour l'obtention de composes a noyau heterocyclique diazote EG16212A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8300954A FR2539741A1 (fr) 1983-01-21 1983-01-21 Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent

Publications (1)

Publication Number Publication Date
EG16212A true EG16212A (en) 1989-06-30

Family

ID=9285183

Family Applications (1)

Application Number Title Priority Date Filing Date
EG40/84A EG16212A (en) 1983-01-21 1984-01-21 Procede pour l'obtention de composes a noyau heterocyclique diazote

Country Status (30)

Country Link
US (1) US4624952A (xx)
EP (1) EP0114770B1 (xx)
JP (1) JPS59137469A (xx)
KR (1) KR910000640B1 (xx)
AT (1) ATE28453T1 (xx)
AU (1) AU563160B2 (xx)
CA (1) CA1217490A (xx)
CS (1) CS242894B2 (xx)
DD (1) DD216014A5 (xx)
DE (1) DE3464909D1 (xx)
DK (1) DK25684A (xx)
EG (1) EG16212A (xx)
ES (1) ES8407040A1 (xx)
FI (1) FI79537C (xx)
FR (1) FR2539741A1 (xx)
GR (1) GR79766B (xx)
HU (1) HU191586B (xx)
IE (1) IE56569B1 (xx)
IL (1) IL70740A (xx)
MA (1) MA20007A1 (xx)
NO (1) NO159170C (xx)
NZ (1) NZ206906A (xx)
OA (1) OA07638A (xx)
PH (1) PH21060A (xx)
PL (1) PL143224B1 (xx)
PT (1) PT77966B (xx)
SG (1) SG2189G (xx)
SU (1) SU1342415A3 (xx)
YU (1) YU10384A (xx)
ZA (1) ZA84342B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
FR2567518B1 (fr) * 1984-07-11 1987-11-13 Sanofi Sa Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent
DE3517617A1 (de) * 1985-05-15 1986-11-20 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Neue pyridaziniumverbindungen, verfahren zu deren herstellung und diese enthaltende fungizide und algizide mittel
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
WO2008096746A1 (ja) * 2007-02-06 2008-08-14 Takeda Pharmaceutical Company Limited スピロ化合物およびその用途
CN107614503B (zh) * 2015-04-29 2020-03-10 广东众生药业股份有限公司 稠环或三环芳基嘧啶化合物用作激酶抑制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
US4302455A (en) * 1980-04-14 1981-11-24 Merck & Co., Inc. 2-(4-Aminopiperidino)pyrazines
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2511366A1 (fr) * 1981-08-11 1983-02-18 Sanofi Sa Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent

Also Published As

Publication number Publication date
FI79537C (fi) 1990-01-10
FI79537B (fi) 1989-09-29
YU10384A (en) 1986-10-31
PT77966A (fr) 1984-02-01
SU1342415A3 (ru) 1987-09-30
ZA84342B (en) 1984-08-29
GR79766B (xx) 1984-10-31
NO159170B (no) 1988-08-29
ES528921A0 (es) 1984-09-01
NO840214L (no) 1984-07-23
DD216014A5 (de) 1984-11-28
KR910000640B1 (ko) 1991-01-31
EP0114770B1 (en) 1987-07-22
DK25684A (da) 1984-07-22
MA20007A1 (fr) 1984-10-01
FR2539741B1 (xx) 1985-05-17
DE3464909D1 (en) 1987-08-27
EP0114770A2 (fr) 1984-08-01
ATE28453T1 (de) 1987-08-15
AU2323684A (en) 1984-07-26
AU563160B2 (en) 1987-07-02
PT77966B (fr) 1986-07-11
IE56569B1 (en) 1991-09-11
IE840102L (en) 1984-07-21
FR2539741A1 (fr) 1984-07-27
DK25684D0 (da) 1984-01-20
CA1217490A (en) 1987-02-03
OA07638A (fr) 1985-05-23
PL143224B1 (en) 1988-01-30
NO159170C (no) 1988-12-07
EP0114770A3 (en) 1984-08-22
SG2189G (en) 1989-06-02
ES8407040A1 (es) 1984-09-01
PH21060A (en) 1987-07-10
US4624952A (en) 1986-11-25
FI840238A (fi) 1984-07-22
NZ206906A (en) 1987-05-29
CS42484A2 (en) 1985-08-15
IL70740A0 (en) 1984-04-30
CS242894B2 (en) 1986-05-15
PL245836A1 (en) 1985-07-02
FI840238A0 (fi) 1984-01-20
HU191586B (en) 1987-03-30
JPS59137469A (ja) 1984-08-07
IL70740A (en) 1986-09-30
KR840007406A (ko) 1984-12-07

Similar Documents

Publication Publication Date Title
EG16212A (en) Procede pour l'obtention de composes a noyau heterocyclique diazote
FR2318851A1 (fr) Procede d'hydroxylation de composes aromatiques
RO92378A (ro) Procedeu pentru prepararea unor derivati ai 1,2,4-tiadiazolului
BE848452A (fr) Composes intermediaires pour la synthese d'antibiotiques quinoniques pclycycliques, et procede de preparation de ces antibiotiques
RO91422A (ro) Procedeu pentru prepararea unor derivati de 1,3-oxazolidin-2-ona
FR2335522A1 (fr) Procede de preparation d'androstene-4 diones-3,17
RO79385A (ro) Procedeu pentru prepararea unor derivati ai amidei acidului 1,2,3-tiadiazol-5-carboxilic
FR2314192A1 (fr) Procede de preparation d'oxaphospholannes-1,2
BE875518A (fr) Procede pour la preparation des n-phenyl-para-phenylene-diamines asymetriques substituees sur l'atome d'azote n'
FR2327995A1 (fr) Procede ameliore de preparation de vanadate d'ethyle
BE857650A (fr) Procede de preparation de composes d'alcoxymethylene
FR2348187A1 (fr) Procede d'hydrogenation de composes nitres, nitroses ou hydroxylamines pour la preparation de composes hydroxylamines ou amines
MA20491A1 (fr) Procede de preparation d'aminomethylene-2 indanedione-1,3 substituees sur l'azote
RO79906A (ro) Procedeu pentru prepararea unor derivati de 1,1'-difenil 2-ilalchilamina
RO72832A (ro) Procedeu pentru prepararea n-(2'-furanidil)-5-fluoro-uracilului
FR2317307A1 (fr) Procede de preparation d'oxaphospholannes-1,2
RO85279A (ro) Procedeu pentru prepararea unor derivati de 1,2,3-tiadiazol
FR2332272A1 (fr) Procede de preparation de l'e-caprolactame
BE810712A (fr) Procede pour l'elimination de l'ammoniac
PT72667B (fr) Nouveau procede de preparation du n,n-dimethyl-<aza-1-bicyclo- -(2,2,2)-octyl-3>-10-10h-phenothiazinesulfonamide-2
FR1252953A (fr) Procédé pour la préparation de formes d'impression à partir de polyamides
YU41134B (en) Process for the purification of 2,4-diamino-5-(3,4,5-trimehoxybenzyl)-pyramidine
FR2564452B1 (fr) Procede de preparation d'ammoniac et ammoniac obtenu par ledit procede